Long-term Effectiveness and Safety in Hepatitis-co-infected Patients
Long-term Effectiveness and Safety in Hepatitis-co-infected Patients
The aim of the study is to observe the tolerability and effectiveness of Kaletra in Human Immunodeficiency Virus/Hepatitis-B Virus and Human Immunodeficiency Virus/Hepatitis-C Virus co-infected patients.
Inclusion Criteria:
Exclusion Criteria:
- Contraindications as described in SmPC (summary of product characteristics) at the time of prescription